These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease. Kurstin R Oncology (Williston Park); 2002 Jan; 16(1):21-4. PubMed ID: 11831608 [No Abstract] [Full Text] [Related]
3. Upper Gastrointestinal Bleeding Caused by Hereditary Hemorrhagic Telangectasia. Li W; Kotha S; Joshi D Clin Gastroenterol Hepatol; 2017 Jul; 15(7):A25-A26. PubMed ID: 28342953 [No Abstract] [Full Text] [Related]
4. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. Wang XY; Chen Y; Du Q Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527 [TBL] [Abstract][Full Text] [Related]
5. Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome. Das BB; Chan KC Cardiovasc Hematol Agents Med Chem; 2020; 18(1):70-76. PubMed ID: 31657683 [TBL] [Abstract][Full Text] [Related]
6. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia? Pérez-Encinas M; Rabuñal Martínez MJ; Bello López JL Haematologica; 2002 Aug; 87(8):ELT34. PubMed ID: 12161379 [No Abstract] [Full Text] [Related]
7. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study. Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273 [TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management. Becq A; Rahmi G; Perrod G; Cellier C Gastrointest Endosc; 2017 Nov; 86(5):792-806. PubMed ID: 28554655 [No Abstract] [Full Text] [Related]
9. Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide. Lacout A; Marcy PY; El Hajjam M; Lacombe P Med Hypotheses; 2013 May; 80(5):587-8. PubMed ID: 23452644 [TBL] [Abstract][Full Text] [Related]
10. Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review. Chen CH; Hsu HH; Hu RH; Lee PH; Ho CM J Clin Pharmacol; 2012 Sep; 52(9):1436-40. PubMed ID: 22031620 [No Abstract] [Full Text] [Related]
12. Thalidomide for hereditary haemorrhagic telangiectasia. Franchini M; Lippi G Lancet Haematol; 2015 Nov; 2(11):e457-8. PubMed ID: 26686252 [No Abstract] [Full Text] [Related]
13. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life. Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465 [TBL] [Abstract][Full Text] [Related]
14. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Bowcock SJ; Patrick HE Br J Haematol; 2009 Jul; 146(2):220-2. PubMed ID: 19438503 [No Abstract] [Full Text] [Related]
15. Technetium-99m-labeled RBC bleeding scan in a patient with Osler-Weber-Rendu Disease. Blumenthal BM; Slizofski W; Hoffman M Clin Nucl Med; 2004 Dec; 29(12):861-3. PubMed ID: 15545910 [No Abstract] [Full Text] [Related]